Wong, K. A., Worth, A., Martin, R., Svarovskaia, E., Brainard, D. M., Lawitz, E., . . . Mo, H. (2013). Characterization of Hepatitis C Virus Resistance from a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885. American Society for Microbiology.
Citação norma ChicagoWong, Kelly A., Angela Worth, Ross Martin, Evguenia Svarovskaia, Diana M. Brainard, Eric Lawitz, Michael D. Miller, and Hongmei Mo. Characterization of Hepatitis C Virus Resistance From a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885. American Society for Microbiology, 2013.
Citação norma MLAWong, Kelly A., et al. Characterization of Hepatitis C Virus Resistance From a Multiple-Dose Clinical Trial of the Novel NS5A Inhibitor GS-5885. American Society for Microbiology, 2013.